Recall Register

Drug recall: FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 5 oz., Rx only, Manufactured for CutisPharma…

Class III FDA enforcement event 75490. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

CutisPharma, Inc. started this drug recall on 20 Oct 2016. The firm address in the FDA record is in Wilmington, MA. FDA put the recall in Class III. FDA event 75490 has 2 product records. The first FDA enforcement report date is 23 Nov 2016. The record gives the status Terminated, with the termination date 12 Sep 2017.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide

Recalling firm

CutisPharma, Inc., Wilmington, MA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 75490: product records
Recall numberProductQuantityClassStatusReport date
D-0138-2017FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 5 oz., Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-058,748 kitsClass IIITerminated23 Nov 2016
D-0139-2017FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 3 OZ, Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-035904 kitsClass IIITerminated23 Nov 2016

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2016
288
Share of these events in Class III
43%
Product records in this event
2
Events of the firm on the register
1

Official channels

Cite this page

Recall Register. FDA enforcement event 75490. https://recallregister.com/fda/iii/75490/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 75490?
The event has 2 product records. The first record gives this quantity: 8,748 kits
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2016 have the same class?
43% of the 288 drug events that started in 2016 are in Class III.